Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis

EJNMMI Research

Table 3 Healthy volunteers with 18-hour fasting

No.	Age (years)	Gender	BMI	Fasting duration (h)	FBG (mg/dL)	FFA0 (mEq/L)	Phy U	SUV_max	Polar map pattern
1	68	Male	27.4	18	86	0.56	1	3.54
2	64	Female	22.3	18	90	0.5	1	3.06
3	56	Male	22.5	16	87	0.63	3	7.23	Basal lateral
4	42	Male	27.1	23	88	0.24	4	20.35	Diffuse
5	64	Female	27.9	18	95	0.73	1	3.05
6	66	Male	21.7	17	74	1.31	1	2.71
7	39	Male	23.4	18	88	0.58	1	2.78
8	41	Male	27.4	18	92	0.52	2	5.05	Basal lateral
9	72	Female	19.8	18	100	0.41	2	3.3	Basal lateral
10	44	Female	24.2	18	78	0.72	4	6.88	Diffuse
11	68	Female	22.2	18	77	0.96	1	2.13
12	41	Female	19.0	18	75	0.273	2	3.62	Basal lateral
13	52	Male	28.6	18	78	0.539	3	5.9	Basal lateral
14	50	Female	23.3	22	78	0.725	1	1.84
15	40	Male	29.0	18.5	107	0.649	1	1.61
16	44	Male	21.8	18.5	68	0.731	1	1.55
17	63	Male	19.7	18	73	0.594	1	1.31
18	47	Male	25.4	18	79	0.872	1	1.48
19	55	Male	30.0	18	104	0.547	1	1.83

BMI, body mass index; FBG, fasting blood glucose; FFA0, free fatty acid at baseline (normal range; 0.10 to 0.81 mEq/L); Phy U, physiological uptake (grading scale) 1 to 4; SUVmax, maximal standard uptake value.